Complete Filing Data
Praxis Precision Medicines, Inc. reported Stockholders Equity of $878.14 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Praxis Precision Medicines, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$303.3M | -$182.8M | -$123.3M | -$214.0M | -$167.1M | -$61.8M | -$35.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$91.0K | $654.0K | $173.0K | $3.0K | |||
| Research And Development Expense | $267.1M | $152.4M | $86.8M | $155.0M | $120.3M | $45.0M | $29.6M |
| Operating Income Loss | -$326.2M | -$200.2M | -$126.4M | -$215.0M | -$167.3M | -$62.0M | -$35.8M |
| Operating Expenses | $326.2M | $208.7M | $128.8M | $215.0M | $167.3M | $62.0M | $35.8M |
| Nonoperating Income Expense | $22.9M | $17.3M | $3.1M | $957.0K | $271.0K | $140.0K | $193.0K |
| General And Administrative Expense | $59.1M | $56.3M | $42.1M | $59.9M | $47.1M | $17.0M | $6.2M |
| Comprehensive Income Net Of Tax | -$303.4M | -$182.2M | -$123.1M | -$214.0M | -$167.2M | -$61.8M | |
| Other Nonoperating Income Expense | $22.9M | $17.3M | $3.1M | $957.0K | |||
| Revenues | $0.00 | $8.6M | $2.4M | $0.00 | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$167.1M | -$61.8M | -$35.6M | ||||
| Income Tax Expense Benefit | $0.00 | -$8.0K | -$84.0K | ||||
| Net Income Loss Available To Common Stockholders Basic | -$167.1M | -$70.3M | -$40.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$73.9M | -$71.1M | -$69.3M | -$58.7M | -$51.9M | -$32.7M | -$39.6M | -$26.9M | -$24.6M | -$34.3M | -$37.5M | -$41.2M | -$43.9M | -$60.2M | -$68.7M | -$58.6M | -$44.7M | -$36.4M | -$27.4M | -$25.7M | -$16.2M | -$11.6M | -$8.3M | -$10.6M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $105.0K | -$264.0K | $5.0K | -$677.0K | $1.4M | -$74.0K | $3.0K | $0.00 | $19.0K | $154.0K | $363.0K | $144.0K | -$74.0K | -$430.0K | -$151.0K | $25.0K | $36.0K | -$86.0K | $0.00 | $0.00 | $0.00 | |||
| Research And Development Expense | $65.8M | $63.0M | $60.8M | $41.9M | $27.3M | $27.0M | $17.3M | $25.6M | $25.5M | $30.4M | $43.6M | $52.7M | $33.1M | $25.7M | $17.9M | $12.8M | $9.1M | $6.9M | $9.3M | |||||
| Operating Income Loss | -$78.4M | -$76.1M | -$74.7M | -$56.8M | -$37.5M | -$41.9M | -$25.5M | -$35.0M | -$38.1M | -$44.3M | -$60.4M | -$68.8M | -$44.8M | -$36.5M | -$27.4M | -$16.2M | -$11.6M | -$8.5M | -$10.7M | |||||
| Operating Expenses | $78.4M | $76.1M | $74.7M | $57.1M | $37.8M | $42.3M | $26.0M | $35.7M | $38.8M | $44.3M | $60.4M | $68.8M | $44.8M | $36.5M | $27.4M | $16.2M | $11.6M | $8.5M | $10.7M | |||||
| Nonoperating Income Expense | $4.4M | $4.9M | $5.4M | $4.9M | $4.8M | $2.3M | $884.0K | $648.0K | $636.0K | $345.0K | $200.0K | $132.0K | $73.0K | $82.0K | $46.0K | $1.0K | $5.0K | $128.0K | $48.0K | |||||
| General And Administrative Expense | $12.6M | $13.1M | $13.9M | $15.3M | $10.6M | $15.3M | $8.7M | $10.1M | $13.3M | $13.9M | $16.8M | $16.2M | $11.6M | $10.8M | $9.5M | $3.4M | $2.5M | $1.6M | $1.3M | |||||
| Comprehensive Income Net Of Tax | -$73.8M | -$71.4M | -$69.3M | -$50.5M | -$32.8M | -$39.6M | -$24.6M | -$34.3M | -$37.3M | -$43.8M | -$60.3M | -$69.1M | -$44.7M | -$36.4M | -$27.5M | -$16.2M | -$11.6M | -$8.3M | ||||||
| Other Nonoperating Income Expense | $4.4M | $4.9M | $5.4M | $4.9M | $4.8M | $2.3M | $884.0K | $648.0K | $636.0K | $345.0K | $200.0K | $132.0K | $73.0K | $82.0K | $46.0K | $1.0K | $5.0K | |||||||
| Revenues | $0.00 | $0.00 | $0.00 | $302.0K | $357.0K | $431.0K | $468.0K | $781.0K | $683.0K | $0.00 | $0.00 | $0.00 | ||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$43.9M | -$44.7M | -$36.4M | -$27.4M | -$16.2M | -$11.6M | -$8.3M | -$10.6M | ||||||||||||||||
| Income Tax Expense Benefit | $0.00 | $5.0K | $0.00 | $0.00 | $0.00 | $3.0K | -$11.0K | |||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$44.7M | -$36.4M | -$27.4M | -$20.2M | -$13.6M | -$9.9M | -$11.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $878.1M | $445.5M | $69.7M | $76.1M | $250.8M | $287.5M | -$81.0M | -$41.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $357.7M | $215.8M | $81.7M | $62.0M | $139.7M | $297.2M | $45.4M | $18.6M |
| Cash And Cash Equivalents At Carrying Value | $357.3M | $215.4M | $81.3M | $61.6M | $138.7M | $296.6M | $44.8M | |
| Operating Lease Right Of Use Asset | $92.0K | $1.1M | $2.1M | $2.9M | $3.7M | $754.0K | $1.5M | |
| Retained Earnings Accumulated Deficit | -$1.14B | -$836.7M | -$653.9M | -$530.6M | -$316.6M | -$149.6M | -$81.0M | |
| Property Plant And Equipment Net | $147.0K | $230.0K | $588.0K | $971.0K | $1.2M | $82.0K | $128.0K | |
| Prepaid Expense And Other Assets Current | $11.6M | $11.8M | $3.6M | $10.4M | $11.5M | $5.7M | $681.0K | |
| Other Assets Noncurrent | $0.00 | $416.0K | $416.0K | $416.0K | $472.0K | $15.0K | $620.0K | |
| Operating Lease Liability Current | $110.0K | $1.3M | $1.1M | $1.0M | $810.0K | $763.0K | $696.0K | |
| Liabilities Current | $59.8M | $37.6M | $15.7M | $34.3M | $38.4M | $15.7M | $6.8M | |
| Liabilities And Stockholders Equity | $937.9M | $483.1M | $87.9M | $115.1M | $292.7M | $303.2M | $47.7M | |
| Liabilities | $59.8M | $37.7M | $18.3M | $39.0M | $41.9M | $15.7M | $7.6M | |
| Common Stock Value | $15.0K | $14.0K | $13.0K | $5.0K | $5.0K | $4.0K | $1.0K | |
| Assets Current | $610.9M | $404.4M | $84.9M | $110.8M | $287.4M | $302.3M | $45.5M | |
| Assets | $937.9M | $483.1M | $87.9M | $115.1M | $292.7M | $303.2M | $47.7M | |
| Accrued Liabilities Current | $35.0M | $23.8M | $7.4M | $15.9M | $26.8M | $10.9M | $3.5M | |
| Accounts Payable Current | $24.6M | $12.5M | $5.8M | $14.7M | $10.8M | $4.1M | $2.7M | |
| Other Operating Activities Cash Flow Statement | $0.00 | $2.0K | $0.00 | $56.0K | -$41.0K | $5.0K | -$22.0K | |
| Operating Lease Right Of Use Asset Amortization Expense | $1.0M | $933.0K | $837.0K | $752.0K | $1.4M | $696.0K | $642.0K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Operating Lease Liability Noncurrent | $0.00 | $110.0K | $1.4M | $2.5M | $3.5M | $0.00 | $763.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $142.0M | $134.1M | $19.7M | -$77.7M | -$157.5M | $251.8M | $26.9M | |
| Accretion Amortization Of Discounts And Premiums Investments | $3.6M | $5.0M | -$47.0K | -$1.0M | -$2.1M | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $563.0K | $654.0K | $0.00 | -$173.0K | -$176.0K | $0.00 | ||
| Restricted Cash | $416.0K | $416.0K | $416.0K | $416.0K | ||||
| Available For Sale Securities Debt Securities | $0.00 | $38.9M | $137.2M | $0.00 | ||||
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | $0.00 | $113.0K | ||||||
| Contract With Customer Liability Noncurrent | $0.00 | $1.2M | $2.2M | $0.00 | ||||
| Contract With Customer Liability Current | $0.00 | $1.4M | $2.8M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $343.5M | $404.2M | $439.2M | $382.7M | $419.1M | $229.7M | -$72.1M | -$60.5M | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $149.9M | $157.8M | $166.0M | $169.1M | $145.6M | $152.4M | $101.5M | $124.7M | $81.3M | $62.9M | $56.5M | $78.3M | $166.7M | $176.9M | $131.8M | $115.4M | $20.3M | $6.8M | $4.9M | |
| Cash And Cash Equivalents At Carrying Value | $149.5M | $157.4M | $165.6M | $168.6M | $145.1M | $152.0M | $101.1M | $124.3M | $80.8M | $62.4M | $56.0M | $77.9M | $165.7M | $175.9M | $131.2M | $114.8M | $19.7M | $6.2M | $4.3M | |
| Operating Lease Right Of Use Asset | $362.0K | $626.0K | $882.0K | $1.4M | $1.6M | $1.8M | $2.3M | $2.5M | $2.7M | $3.1M | $3.3M | $3.5M | $4.4M | $571.0K | $933.0K | |||||
| Retained Earnings Accumulated Deficit | -$1.05B | -$977.2M | -$906.0M | -$778.1M | -$726.2M | -$693.5M | -$627.0M | -$602.4M | -$568.1M | -$489.5M | -$445.5M | -$385.3M | -$258.0M | -$213.3M | -$176.9M | -$123.3M | ||||
| Property Plant And Equipment Net | $174.0K | $258.0K | $247.0K | $277.0K | $369.0K | $476.0K | $700.0K | $759.0K | $865.0K | $1.1M | $1.1M | $1.1M | $625.0K | $182.0K | $109.0K | $98.0K | ||||
| Prepaid Expense And Other Assets Current | $6.7M | $5.3M | $5.6M | $3.0M | $4.8M | $4.4M | $2.2M | $5.5M | $8.6M | $8.6M | $10.2M | $12.0M | $5.0M | $9.2M | $7.8M | $1.1M | ||||
| Other Assets Noncurrent | $0.00 | $0.00 | $0.00 | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $496.0K | $9.0K | $2.1M | ||||
| Operating Lease Liability Current | $436.0K | $755.0K | $1.1M | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $1.0M | $977.0K | $949.0K | $1.0M | $681.0K | $553.0K | $578.0K | $746.0K | ||||
| Liabilities Current | $52.9M | $48.6M | $39.5M | $32.9M | $20.6M | $18.8M | $16.8M | $24.4M | $29.9M | $29.0M | $38.5M | $45.2M | $24.8M | $15.8M | $13.7M | $10.4M | ||||
| Liabilities And Stockholders Equity | $396.4M | $452.8M | $478.7M | $416.3M | $441.1M | $250.4M | $106.7M | $133.5M | $98.4M | $136.9M | $180.4M | $239.5M | $324.4M | $353.5M | $279.3M | $119.5M | ||||
| Liabilities | $52.9M | $48.6M | $39.5M | $33.6M | $22.0M | $20.7M | $20.0M | $27.9M | $33.9M | $31.7M | $41.5M | $48.5M | $28.5M | $19.7M | $13.7M | $10.6M | ||||
| Common Stock Value | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $1.0K | ||||
| Assets Current | $273.8M | $306.6M | $333.6M | $360.0M | $356.7M | $211.8M | $103.3M | $129.8M | $94.4M | $132.3M | $175.6M | $234.5M | $319.3M | $348.4M | $278.6M | $115.9M | ||||
| Assets | $396.4M | $452.8M | $478.7M | $416.3M | $441.1M | $250.4M | $106.7M | $133.5M | $98.4M | $136.9M | $180.4M | $239.5M | $324.4M | $353.5M | $279.3M | $119.5M | ||||
| Accrued Liabilities Current | $21.6M | $19.0M | $15.5M | $15.5M | $10.1M | $7.0M | $7.0M | $13.3M | $9.4M | $17.9M | $25.8M | $30.9M | $16.5M | $7.8M | $7.4M | $6.2M | ||||
| Accounts Payable Current | $30.8M | $28.8M | $22.9M | $15.0M | $8.2M | $9.4M | $7.2M | $8.0M | $17.0M | $10.1M | $11.8M | $13.3M | $7.5M | $7.4M | $5.8M | $3.5M | ||||
| Other Operating Activities Cash Flow Statement | -$2.0K | -$2.0K | $0.00 | $56.0K | $7.0K | $4.0K | ||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $249.0K | $224.0K | $201.0K | $180.0K | $183.0K | $169.0K | ||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Operating Lease Liability Noncurrent | $0.00 | $0.00 | $0.00 | $436.0K | $755.0K | $1.1M | $1.7M | $1.9M | $2.2M | $2.8M | $3.0M | $3.3M | $3.7M | $4.0M | $198.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$49.8M | $70.7M | $19.2M | -$61.5M | -$165.5M | |||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.2M | $84.0K | -$45.0K | -$375.0K | -$261.0K | $0.00 | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $500.0K | $395.0K | $659.0K | $1.3M | -$71.0K | $3.0K | $0.00 | $0.00 | -$19.0K | -$536.0K | -$680.0K | -$606.0K | -$25.0K | -$50.0K | -$86.0K | |||||
| Restricted Cash | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $416.0K | $1.0M | $1.0M | $600.0K | $600.0K | $600.0K | |||
| Available For Sale Securities Debt Securities | $0.00 | $0.00 | $5.0M | $61.3M | $109.4M | $144.7M | $148.7M | $163.3M | $139.7M | |||||||||||
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | $0.00 | $36.0K | ||||||||||||||||||
| Contract With Customer Liability Noncurrent | $293.0K | $588.0K | $866.0K | $1.5M | $1.5M | $1.8M | ||||||||||||||
| Contract With Customer Liability Current | $1.2M | $1.2M | $1.3M | $1.6M | $2.0M | $2.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments Related To Tax Withholding For Share Based Compensation | $2.1M | $308.0K | $137.0K | ||||
| Share Based Compensation | $33.9M | $41.4M | $24.9M | $28.6M | $22.7M | $5.2M | $668.0K |
| Net Cash Provided By Used In Operating Activities | -$249.1M | -$131.8M | -$111.1M | -$185.0M | -$124.6M | -$52.6M | -$33.4M |
| Net Cash Provided By Used In Financing Activities | $702.2M | $514.3M | $91.9M | $10.5M | $107.6M | $304.4M | $60.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$640.0K | $8.2M | -$6.8M | -$547.0K | $5.8M | $4.4M | -$495.0K |
| Increase Decrease In Accrued Liabilities | $11.2M | $16.1M | -$8.5M | -$10.5M | $15.5M | $7.4M | $1.7M |
| Increase Decrease In Accounts Payable | $12.1M | $6.7M | -$8.9M | $3.9M | $7.3M | $960.0K | -$837.0K |
| Net Cash Provided By Used In Investing Activities | -$311.1M | -$248.5M | $39.0M | $96.9M | -$140.5M | $0.00 | -$103.0K |
| Payments To Acquire Available For Sale Securities Debt | $623.8M | $371.5M | $0.00 | $83.0M | $164.2M | $0.00 | |
| Increase Decrease In Operating Lease Liabilities | -$1.1M | -$1.0M | -$811.0K | -$763.0K | -$696.0K | -$633.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $312.7M | $123.0M | $39.0M | $180.4M | $24.7M | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $56.0K | $0.00 | $50.0K | $444.0K | $1.1M | $0.00 | $103.0K |
| Payments Related To Tax Withholding For Share Based Compensation | $2.1M | $308.0K | $137.0K | $260.0K | $0.00 | ||
| Payments Of Stock Issuance Costs | $0.00 | $262.0K | $575.0K | ||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 13.3M | 2.6M | 416.0K | 1.4M | |||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$2.6M | -$2.4M | $5.0M | $0.00 | ||
| Proceeds From Stock Options Exercised | $1.4M | $2.4M | $88.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments Related To Tax Withholding For Share Based Compensation | $52.0K | $23.0K | $1.2M | $157.0K | $1.0K | $13.0K | $137.0K | $5.0K | $1.0K | $4.0K | $127.0K | $7.0K | $6.0K | $17.0K | $230.0K | |||||||
| Share Based Compensation | $8.8M | $14.5M | $7.6M | $7.9M | $4.7M | $147.0K | ||||||||||||||||
| Net Cash Provided By Used In Operating Activities | -$53.0M | -$20.9M | -$32.8M | -$54.1M | -$25.7M | -$8.6M | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $54.3M | $182.8M | $18.1M | $1.2M | $276.0K | -$30.0M | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$6.6M | $808.0K | -$1.8M | $1.1M | $2.0M | $294.0K | ||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$8.3M | -$608.0K | -$6.5M | $4.6M | -$3.5M | -$1.1M | ||||||||||||||||
| Increase Decrease In Accounts Payable | $10.4M | $3.6M | $2.3M | $2.5M | $2.2M | $991.0K | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$51.1M | -$91.2M | $34.0M | -$8.6M | -$140.0M | $0.00 | ||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $117.1M | $91.2M | $0.00 | $83.0M | $140.0M | $0.00 | ||||||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$303.0K | -$271.0K | -$240.0K | -$26.0K | -$185.0K | -$169.0K | ||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $66.0M | $0.00 | $34.0M | $74.8M | $0.00 | |||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $289.0K | $4.0K | $0.00 | ||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $1.2M | $137.0K | $127.0K | $230.0K | $0.00 | |||||||||||||||||
| Payments Of Stock Issuance Costs | $4.5M | $0.00 | $109.0K | $262.0K | $598.0K | $229.0K | $575.0K | $2.9M | $154.0K | $4.0K | $0.00 | |||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 143.0K | 101.0K | 333.0K | |||||||||||||||||||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$431.0K | -$683.0K | $0.00 | ||||||||||||||||||
| Proceeds From Stock Options Exercised | $560.0K | $143.0K | $333.0K | $851.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$13.48 | -$10.21 | -$18.69 | -$69.65 | -$3.94 | -$7.86 | -$26.60 |
| Weighted Average Number Of Shares Outstanding Basic | 22.5M | 17.9M | 6.6M | 3.1M | 42.5M | 9.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 22.5M | 17.9M | 6.6M | 3.1M | 42.5M | 9.0M | |
| Earnings Per Share Basic | $-13.48 | $-10.21 | $-18.69 | $-69.65 | $-3.94 | $-7.86 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 25.2M | 19.4M | 8.8M | 3.3M | 45.3M | 38.3M | 1.6M |
| Common Stock Shares Issued | 25.2M | 19.4M | 8.8M | 3.3M | 45.3M | 38.3M | 1.7M |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 46.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.36 | -$3.31 | -$3.29 | -$2.75 | -$1.74 | -$2.84 | -$2.72 | -$7.38 | -$10.58 | -$0.96 | -$1.32 | -$1.51 | -$1.00 | -$0.88 | -$0.71 | -$12.10 | -$8.28 | -$6.08 | -$7.61 |
| Weighted Average Number Of Shares Outstanding Basic | 22.0M | 21.5M | 21.1M | 18.9M | 18.8M | 13.9M | 9.0M | 4.6M | 3.5M | 45.8M | 45.5M | 45.5M | 44.7M | 41.6M | 38.5M | 1.7M | 1.6M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 22.0M | 21.5M | 21.1M | 18.9M | 18.8M | 13.9M | 9.0M | 4.6M | 3.5M | 45.8M | 45.5M | 45.5M | 44.7M | 41.6M | 38.5M | 1.7M | 1.6M | ||
| Earnings Per Share Basic | $-3.36 | $-3.31 | $-3.29 | $-2.75 | $-1.74 | $-2.84 | $-2.72 | $-7.38 | $-10.58 | $-0.96 | $-1.32 | $-1.51 | $-1.00 | $-0.88 | $-0.71 | $-12.10 | $-8.28 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 21.2M | 21.0M | 20.3M | 17.8M | 17.8M | 13.3M | 128.5M | 128.5M | 58.0M | 46.9M | 45.6M | 45.5M | 44.8M | 44.7M | 38.6M | 1.7M | |||
| Common Stock Shares Issued | 21.2M | 21.0M | 20.3M | 17.8M | 17.8M | 13.3M | 128.5M | 128.5M | 58.0M | 46.9M | 45.6M | 45.5M | 44.8M | 44.7M | 38.6M | 1.7M | |||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 70.5M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $33.9M | $41.4M | $24.9M | $5.2M | $668.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $12.6M | $2.1M | $102.0K | $88.0K | |||
| Depreciation | $140.0K | $358.0K | $432.0K | $419.0K | $182.0K | $50.0K | $37.0K |
| Additional Paid In Capital | $2.02B | $1.28B | $723.6M | $606.9M | $567.6M | $437.0M | $0.00 |
| Stock Issued During Period Value New Issues | $200.3M | ||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $717.0K | $544.0K | $314.0K | ||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $267.0K | $4.0K | $0.00 | |||
| Stock Issued During Period Shares Stock Options Exercised | 220.3K | 45.2K | 3.3K | 265.7K | 890.0K | 30.5K | |
| Collaboration And License Agreement Noncash Expense | $0.00 | $2.5M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.4M | $7.8M | $8.8M | $8.6M | $12.4M | $5.9M | $14.5M | $5.7M | $5.8M | $5.8M | $7.6M | $6.4M | $6.7M | $7.6M | $7.9M | $6.1M | $6.5M | $5.4M | $4.7M | $3.8M | $953.0K | $285.0K | $147.0K | $276.0K |
| Stock Issued During Period Value Stock Options Exercised | $808.0K | $560.0K | $201.0K | $4.0K | $143.0K | $1.0K | $101.0K | $0.00 | $409.0K | $67.0K | $333.0K | $478.0K | $309.0K | $809.0K | $851.0K | $61.0K | $27.0K | |||||||
| Depreciation | $47.0K | $112.0K | $106.0K | $93.0K | $23.0K | $10.0K | ||||||||||||||||||
| Additional Paid In Capital | $1.39B | $1.38B | $1.34B | $1.16B | $1.15B | $923.1M | $713.8M | $708.0M | $632.6M | $595.2M | $585.1M | $577.0M | $554.0M | $547.1M | $442.5M | |||||||||
| Stock Issued During Period Value New Issues | $1.7M | $4.0M | $18.1M | $5.2M | $3.0M | $454.0K | $1.4M | $7.0M | $98.4M | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $294.0K | $233.0K | $311.0K | $106.0K | $208.0K | $163.0K | $454.0K | |||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $64.0K | $0.00 | $0.00 | $51.0K | $0.00 | |||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 14.4K | 3.6K | 44.6K | 72.3K | 352.5K | |||||||||||||||||||
| Collaboration And License Agreement Noncash Expense | $0.00 | $2.5M | $0.00 |
Most recent annual filing with the SEC: February 19, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.